medigraphic.com
SPANISH

Revista Médica del Instituto Mexicano del Seguro Social

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number S1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2011; 49 (S1)

The cancer registry is fundamental for the treatment, prevention and control of childhood cáncer

González-Miranda G, Fajardo-Gutiérrez A
Full text How to cite this article

Language: Spanish
References: 17
Page: 33-38
PDF size: 183.68 Kb.


Key words:

Registries diseases, registries, neoplasms.

ABSTRACT

During the last 10 years cancer in the Mexican pediatric population is growing. It is the second leading cause of death (children 1 to 14 years of age). The first step in controlling these diseases by registering the cases. Cancer Registry (CR) is fundamental for gaining knowledge that can be used for planning medical treatment and future research into causal factors and for the prevention. A CR is an information system designed to collect and encode data concerning individuals with cancer, and then to disseminate the compiled epidemiological results to various groups of stakeholders. Data are obtained from a hospital or group of hospitals, with special emphasis being placed on the quality of the data (completeness, validity and timeliness data). It is necessary a group of highly trained individuals called registrars, who are experts in the collection, encoding, and dissemination of internal reports to researchers and medical personnel. There are two main types of registries: those that are hospital based and those that are population based. The categories of data that should be collected are demographic data of the patient; descriptors of the cancer; details of the treatment administered; and details of the outcome of the treatment. It must be emphasized that all data concerning patients with cancer should be held in the strictest confidence.


REFERENCES

  1. Juárez-Ocaña S, Mejía-Aranguré JM, Rendón-Macías ME, Kauffman-Nieves A, Yamamoto-Kimura LT, Fajardo-Gutiérrez A. Tendencia de seis principales causas de mortalidad en niños mexicanos durante el periodo de 1971-2000. La transición epidemiológica en los niños. Gac Med Mex 2003;139(4):19-29.

  2. Instituto Nacional de Estadística y Geografía. [Sitio web]. México: INEGI; 2006. Principales causas de mortalidad por residencia habitual, grupos de edad y sexo. Disponible en: http//:www.inegi.org.mx

  3. Hutchison CL, Menck HR, Burch M, Gottschalk R. Cancer registry management. Principles & Practice. Second edition. Iowa: Kendall/Hunt Publishing; 2004.

  4. National Cancer Institute. [Sitio web]. Seer Training Modules. Cancer Registration Module. Disponible en http:// training.seer.cancer.gov/registration/registry/

  5. Nacional Cancer Registrars Association. [Sitio web]. Quality Cancer Data Save Lives. The vital role of cancer registrars in the fight against cancer. Disponible en http://www. cdc.gov/cancer/npcr/pdf/QualityData90min.pdf

  6. National Cancer Institute. [Sitio web]. Seer Training Modules Cancer Registry Operations & Procedures, Data Standards, Standard Setters, National Cancer Registrars Association. Disponible en http://training.seer. cancer.gov/ operations/standards/setters/ncra.html

  7. Rivera-Luna R, Leal-Leal C, Cárdenas-Cardos R, MartinezÁvalos A, Meza-Coria C, Navarro-Alegría I, Ruano-Aguilar J. A survey of 4076 children with cancer. Certain epidemiological aspects from a single Institution. Bol Med Hosp Infant Mex 1996;53:598-605.

  8. Linet MS, Ries LAG, Smith MA, Tarone RE, Devesa SS: Cancer surveillance series: Recent trends in childhood cancer incidence and mortality in the Unitecd States. J Natl Cancer Inst 1999;91:1051-1058.

  9. Dreifaldt AC, Carlberg M, Hardell L: Increasing incidence rates of childhood malignant diseases in Sweden during the period 1960-1998. Eur J Cancer 2004;40:1351-1360.

  10. Desandes E, Clavel J, Berger C, Bernard JL, Blouin P, de Lumley L, et al. Cancer incidence among children in France, 1990-1999. Pediatr Blood Cancer 2004;43:749-757.

  11. Fritz A, Percy C, Jack A. Shanmugaratnam K, Sobin L, Parkin DM, et al. International Classification of Diseases for Oncology. Third edition. Geneva: World Health Organization; 2000.

  12. Greene FL, Page DL, Fleming ID, Fritz AG, Balch ChM, Haller DG; editores. AJCC Staging Manual, 6th ed. New York: Springer-Verlag, 2002

  13. National Cancer Institute. [Sitio web]. Seer Training Modules SEER Extent of Disease Coding (EOD). Disponible en http://training.seer.cancer.gov/staging/systems/ eod.html

  14. Young JL, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, SEER Summary Staging Manual-2000: Codes and Coding Instructions, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD. 2001.

  15. National Cancer Institute. [Sitio web]. References. Intro to Collaborative Staging. US. Nationasl Institutes of Health. Disponible en http://training.seer.cancer.gov/collaborative/

  16. Steliarova-Foucher E, Stiller CA, Lacour B, Kaatsch P. International classification of childhood cancer. Third edition. Cancer 2005;103:1457-1467.

  17. Children´s Oncology Group. Children’s caner. Disponible en http://www.childrenosoncologygroup.org; ohttp:// www.curesearch.org/our_research/index_sub.aspx? id=1469




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Inst Mex Seguro Soc. 2011;49